Literature DB >> 22851758

Successful extracorporeal membrane oxygenation weaning after cardiac resynchronization therapy device implantation in a patient with end-stage heart failure.

Simon Pecha1, Yalin Yildirim, Hermann Reichenspurner, Tobias Deuse.   

Abstract

We present the case of a 46-year old male with end-stage heart failure due to ethyltoxic cardiomyopathy. The patient did not meet the criteria for heart transplantation and declined left ventricular assist device implantation. We decided to conduct cardiac resynchronization therapy defibrillator (CRT-D) implantation. Under general anaesthesia for CRT-D implantation, cardiac function worsened. Due to deteriorating haemodynamics, CRT-D implantation was aborted and emergent veno-arterial extracorporeal membrane oxygenation (ECMO) implantation was performed. Subsequent weaning from ECMO was not possible. We decided to proceed with CRT-D implantation while still on ECMO support. With biventricular stimulation, cardiac function improved promptly and the patient could be weaned from ECMO the same day.

Entities:  

Mesh:

Year:  2012        PMID: 22851758      PMCID: PMC3480607          DOI: 10.1093/icvts/ivs338

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).

Authors:  Alon Barsheshet; Paul J Wang; Arthur J Moss; Scott D Solomon; Amin Al-Ahmad; Scott McNitt; Elyse Foster; David T Huang; Helmut U Klein; Wojciech Zareba; Michael Eldar; Ilan Goldenberg
Journal:  J Am Coll Cardiol       Date:  2011-06-14       Impact factor: 24.094

2.  Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series.

Authors:  Yuval Konstantino; Zaza Iakobishvili; Orna Arad; Tuvia Ben-Gal; Jairo Kusniec; Alexander Mazur; Avital Porter; Boris Strasberg; Alexander Battler; David Hasdai
Journal:  Cardiology       Date:  2006-04-11       Impact factor: 1.869

3.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

4.  Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term study.

Authors:  Paul Milliez; Olivier Thomas; Abdeddayem Haggui; Patrick Schurando; Pierre Squara; Alain Cohen-Solal; Alexandre Mebazaa; Antoine Leenhardt
Journal:  Eur J Heart Fail       Date:  2008-02-29       Impact factor: 15.534

5.  Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study.

Authors:  John G F Cleland; Melanie J Calvert; Yves Verboven; Nick Freemantle
Journal:  Am Heart J       Date:  2009-01-20       Impact factor: 4.749

  5 in total
  3 in total

1.  eComment. Cardiac resynchronization therapy in cardiac surgery.

Authors:  Jamil Hajj-Chahine; Christophe Jayle; Jacques Tomasi; Pierre Corbi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11

2.  Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator.

Authors:  Ji Hyun Bang; You Na Oh; Jae-Kon Ko; So Yeon Kang; Jae Suk Baek; Chun Soo Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-02-05

3.  Cardiac Resynchronization Therapy Device Implantation in a Patient with Cardiogenic Shock under Percutaneous Mechanical Circulatory Support.

Authors:  Kyunghee Lim; Jin-Oh Choi; Jeong Hoon Yang; Seung-Jung Park; Sun Hwa Kim; Jiseok Kang; Hyun Sung Joh; Sun Hye Shin
Journal:  Korean Circ J       Date:  2016-12-23       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.